ALGN vs NBY · P/E 35, rev $2.10B vs $51.9M cap
Align Technology Inc (ALGN) versus NovaBay Pharmaceuticals Inc (NBY) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
NBY does not have a complete income-statement cache yet.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. NBY currently screens at market cap $51.9M.
Not investment advice. Open the ALGN and NBY stock pages for the full models.
Not investment advice.